Julie Monzo Joins Astellas Pharma Inc. (ALPMY) Corporate Affairs

NORTHBROOK, Ill., June 22, 2015 /PRNewswire/ -- Astellas today announced that Julie Monzo has been appointed to the newly created role of senior manager, Global Medical and Development (GMD) communications, as part of the Corporate Affairs department. Monzo will report to Andrew Lewis, head of communications, GMD, and will lead both internal and external global communications programs for the functional groups that comprise GMD, including Clinical Development, Medical Affairs, Pharmacovigilance, Quality Assurance and Regulatory Affairs.

Astellas is a pharmaceutical company dedicated to improving the health of people around the world.
"As a leader in the healthcare community, it is essential for the communications function at Astellas to align its employees with organizational priorities and communicate the Company's scientific and medical expertise to patients, healthcare providers and researchers around the world," said Jeff Winton, senior vice president, chief communications officer, Corporate Affairs. "Julie's deep experience in this space will be invaluable in helping achieve these goals."

Monzo most recently served as senior manager, enterprise communications and public relations at the College of American Pathologists. She previously worked at the McDonald's Corporation and various public relations and advertising agencies. Monzo earned a bachelor's degree in communication studies from the University of Iowa.

Winton oversees the newly formed Corporate Affairs department at Astellas. This department combines State and Federal Government Affairs, Corporate, Employee and Business Communications, Advocacy, Corporate Branding, Corporate Social Responsibility and Corporate Events, effectively uniting the Astellas voice among all internal and external stakeholders.

About Astellas
Astellas is a pharmaceutical company dedicated to improving the health of people around the world through provision of innovative and reliable pharmaceuticals. For more information on Astellas, please visit our website at www.astellas.us, follow us on Twitter at www.twitter.com/AstellasUS or like our Facebook page at www.facebook.com/AstellasUS.

Logo - http://photos.prnewswire.com/prnh/20140416/84970


To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/julie-monzo-joins-astellas-corporate-affairs-300102408.html

SOURCE Astellas

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

NYC’s outstanding talent and funding, the city is rich with life science real estate offerings across the five boroughs.

Sutro Biopharma’s lead antibody-drug conjugate shrank tumors in 13% of patients with ovarian cancer who had tried a median of six other treatments.

Immuno-oncology biotech Silverback Therapeutics has more than doubled its original IPO hopes.